424 related articles for article (PubMed ID: 25541468)
1. Aldose reductase expression as a risk factor for cataract.
Snow A; Shieh B; Chang KC; Pal A; Lenhart P; Ammar D; Ruzycki P; Palla S; Reddy GB; Petrash JM
Chem Biol Interact; 2015 Jun; 234():247-53. PubMed ID: 25541468
[TBL] [Abstract][Full Text] [Related]
2. Osmotic stress, not aldose reductase activity, directly induces growth factors and MAPK signaling changes during sugar cataract formation.
Zhang P; Xing K; Randazzo J; Blessing K; Lou MF; Kador PF
Exp Eye Res; 2012 Aug; 101():36-43. PubMed ID: 22710095
[TBL] [Abstract][Full Text] [Related]
3. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
4. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens.
Lee AY; Chung SK; Chung SS
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2780-4. PubMed ID: 7708723
[TBL] [Abstract][Full Text] [Related]
5. Nonosmotic diabetic cataracts.
Malone JI; Lowitt S; Cook WR
Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of osmotic and oxidative stress in slow-developing cataract formation.
Chan AW; Ho YS; Chung SK; Chung SS
Exp Eye Res; 2008 Nov; 87(5):454-61. PubMed ID: 18760274
[TBL] [Abstract][Full Text] [Related]
7. Contributions of polyol pathway to oxidative stress in diabetic cataract.
Lee AY; Chung SS
FASEB J; 1999 Jan; 13(1):23-30. PubMed ID: 9872926
[TBL] [Abstract][Full Text] [Related]
8. Aldose reductase in diabetic complications of the eye.
Kinoshita JH; Fukushi S; Kador P; Merola LO
Metabolism; 1979 Apr; 28(4 Suppl 1):462-9. PubMed ID: 45423
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of aldose reductase from cataracted eye lenses by finger millet (Eleusine coracana) polyphenols.
Chethan S; Dharmesh SM; Malleshi NG
Bioorg Med Chem; 2008 Dec; 16(23):10085-90. PubMed ID: 18976928
[TBL] [Abstract][Full Text] [Related]
10. Increased lenticular aldose reductase activity and high incidence of congenital cataract in the offspring of diabetic rats.
Simán CM; Naeser P; Eriksson UJ
Acta Ophthalmol (Copenh); 1993 Oct; 71(5):629-36. PubMed ID: 8109209
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of aldose reductase in diabetic complications.
Chung SS; Chung SK
Curr Med Chem; 2003 Aug; 10(15):1375-87. PubMed ID: 12871135
[TBL] [Abstract][Full Text] [Related]
12. Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor.
Yagihashi S; Yamagishi SI; Wada Ri R; Baba M; Hohman TC; Yabe-Nishimura C; Kokai Y
Brain; 2001 Dec; 124(Pt 12):2448-58. PubMed ID: 11701599
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization for aldose reductase in diabetic lenses.
Akagi Y; Kador PF; Kinoshita JH
Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):163-7. PubMed ID: 3100473
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase deficiency protects sugar-induced lens opacification in rats.
Reddy AB; Tammali R; Mishra R; Srivastava S; Srivastava SK; Ramana KV
Chem Biol Interact; 2011 May; 191(1-3):346-50. PubMed ID: 21376710
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of aldose reductase by Aegle marmelos and its protective role in diabetic cataract.
Sankeshi V; Kumar PA; Naik RR; Sridhar G; Kumar MP; Gopal VV; Raju TN
J Ethnopharmacol; 2013 Aug; 149(1):215-21. PubMed ID: 23827758
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Alrestatin, an aldose reductase inhibitor, in human diabetic and nondiabetic lenses.
Chylack LT; Henriques HF; Cheng HM; Tung WH
Ophthalmology; 1979 Sep; 86(9):1579-85. PubMed ID: 121768
[TBL] [Abstract][Full Text] [Related]
17. GP-1447, an inhibitor of aldose reductase, prevents the progression of diabetic cataract in rats.
Kawakubo K; Mori A; Sakamoto K; Nakahara T; Ishii K
Biol Pharm Bull; 2012; 35(6):866-72. PubMed ID: 22687477
[TBL] [Abstract][Full Text] [Related]
18. The sorbitol pathway in the human lens: aldose reductase and polyol dehydrogenase.
Jedziniak JA; Chylack LT; Cheng HM; Gillis MK; Kalustian AA; Tung WH
Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):314-26. PubMed ID: 6782033
[TBL] [Abstract][Full Text] [Related]
19. Involvement of aldose reductase in naphthalene cataract.
Lee AY; Chung SS
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):193-7. PubMed ID: 9430562
[TBL] [Abstract][Full Text] [Related]
20. Etiology of cataracts in diabetics.
Varma SD; Richards RD
Int Ophthalmol Clin; 1984; 24(4):93-110. PubMed ID: 6438012
[No Abstract] [Full Text] [Related]
[Next] [New Search]
